Nvidia, Amgen back AI-driven drug firm Generate:Biomedicines’ $273 million fundraise
(Reuters) – Drug developer Generate:Biomedicines, which uses artificial intelligence (AI)
(Reuters) – Drug developer Generate:Biomedicines, which uses artificial intelligence (AI)